Stimulant medications

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 38, Issue 5, 1999, Pages 503-512

  Greenhill, Laurence L ^a   Halperin, Jeffrey M ^b,e   Abikoff, Howard ^c,d  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Division of Reproductive Endocrinology   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

Author keywords

Attention deficit hyperactivity disorder; Dextroamphetamine; Methylphenidate; Pemoline; Stimulants

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; DEXAMPHETAMINE; METHAMPHETAMINE; METHYLPHENIDATE; PEMOLINE; PEMOLINE MAGNESIUM; PLACEBO; PSYCHOSTIMULANT AGENT;

ANIMAL MODEL; ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD PSYCHIATRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; HEADACHE; HUMAN; LIVER TUMOR; MAJOR CLINICAL STUDY; NERVOUSNESS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RAT; STOMACH PAIN; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032937855     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199905000-00011     Document Type: Short Survey

References (69)

1. American Academy of Child and Adolescent Psychiatry (1997), Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. JAmAcad Child Adolesc Psychiatry 36:855-121S
2. Angold A, Costello E (in press), Stimulant treatment for children: a community perspective. Pediatrics
3. Angrist BM, Gershon S (1972), Psychiatric sequelae of amphetamine use. In: Psychiatric Complications of Medical Drugs, Shader RI, ed. New York: Raven, pp 175-199
4. Arnold L, Jensen P, Richters J et al. (1997), The National Institute of Mental Health Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit Hyperactivity Disorder (MTA), II: methods. Arch Gen Psychiatry 54:865-870
5. Barkley RA, McMurray MB, Edelbrock CS, Robbins K (1990), Side effects of methylphenidate in children with attention deficit hyperactiviry disorder: a systemic, placebo-controlled evaluation. Pediatrics 86:184-192
6. Barkley RA (1977), A review of stimulant drug research with hyperactive children. J Child Psychol Psychiatry 18:137-165
7. 3H]paroxetine-labeled serotonin uptake sites. J PbarmacolExp Ther 242:911-916
8. Berkovitch M, Pope E, Phillips J, Koren G (1995), Pemoline-associated fulminant liver failure: testing the evidence for causation. Clin Pharmacol Ther 57:696-698
9. Bradley C (1937), The behavior of children receiving benzedrine. Am J Psychiatry 94:577-585
10. Douglas VI, Barr RG, Amin K, O'Neill ME, Britton BG (1988), Dose effects and individual responsivity to methylphenidate in attention deficit disorder. J Child Psychol Psychiatry 29:453-475
11. Dunnick J, Hailey J (1995), Experimental studies on the long-term effects of methylphenidate hydrochloride. Toxicology 103:77-84
12. DuPaul G, Barkley R, McMurray M (1994), Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. J Am Acad ChildAdolesc Psychiatry 33:894-903
13. Elia J, Borcherding B, Rapoport J, Keysor C (1991), Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true non-responders? Psychiatry Res 36:141-155
14. Feussner G (1998), Diversion, trafficking, and abuse of methylphenidate. In: NIH Consensus Development Conference: Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder, Program and Abstracts, pp 201-205
15. Fitzpatrick P, Klorman R, Brumaghim J, Borgstedt A (1992), Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder. In: Scicntific Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry 31:226-234
16. Gadow K, Sverd J, Sprafkin J, Nolan E, Ezor S (1995), Efficacy of methylphenidate for attention deficit hyperactivity in children with tic disorder. Arch Gen Psychiatry 52:444-455
17. Gillberg C, Melander H, von Knorring A et al. (1997), Long-term central stimulant treatment of children with attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial. Arch Gen Psychiatry 54:857-864
18. Gittelman-Klein R (1980), Drug treatment of child psychiatric disorders. In: Diagnosis and Drug Treatment of Psychiatric Disorders, 2nd ed, Klein DF, Gittelman R, Quitkin F, Rifkin A, eds. Baltimore: Williams & Wilkins, pp 590-696
19. Gittelman-Klein R (1987), Pharmacotherapy of childhood hyperactivity: an update. In: Psychopharmacology: The Third Generation of Progress, 3rd ed, Meiner HY, ed. New York: Raven, pp 1215-1224
20. Gittelman-Klein R, Landa B, Mattes J, Klein D (1988), Methylphenidate and growth in hyperactive children. Arch Gen Psychiatry 45:1127-1130
21. Goldman L, Genei M, Bazman R, Stonetz P (1998), Diagnosis and treatment of attention-deficit/hyperactivity disorder. JAMA 279:1100-1107
22. Greenhill L (1998), Childhood attention deficit hyperactivity disorder: pharmacological treatments. In: Treatments That Work, Nathan PE, German J, eds. Philadelphia: Saunders, pp 42-64
23. Greenhill L, AbikofF H, Conners CK et al. (1996), Medication treatment strategies in the MTA: relevance to clinicians and researchers. JAmAcad Child Adolesc Psychiatry 35:4.44-454
24. Greenhill L, Halperin J, March] (1997), Psychostimulants. In: Psychiatry, Tasman A, KayJ, Lieberman J, eds. Philadelphia: Saunders, pp 1659-1682
25. Hechtman L, AbikofF H (1995), Multimodal treatment plus stimulants vs stimulant treatment alone in ADHD children: results from a two year comparative treatment study. Paper presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New Orleans, October
26. HinshawS (1991), Stimulant medication and the treatment of aggression in children with attentional defects. J Clin Child Psychol2QM3Q1-312
27. Horn WF, Islongo NS, PascoeJM et al. (1991), Additive effects of psychostimulants, parent training, and self-control therapy with ADHD children. JAmAcad Child Adolesc Psychiatry 30:233-240
28. Jacobvitz D, Srouge LA, Stewart M, Leffert N (1990), Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review. J Am Acad Child Adolfsc Psychiatry 29: 677-688
29. Jensen PS, Kettle L, Roper MT et al. (in press), Are stimulants overprescribed? Treatment of ADHD in four US communities. JAm Acad Child Adolf sc Psychiatry
30. Kent J, Blader J, Koplewicz H, AbikofF H, Foley C (1995), Effects of lateafternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder. Pediatrics 96:320-325
31. Klein R, Abikoff H, Klass E, Ganales D, Seese L, Pollack S (1997), Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry 54:1073-1080
32. Mannuzza S, Klein RG, Bonagura N, Malloy P, Giampino TL, Addalli KA (1991), Hyperactive boys almost grown up, V: replication of psychiatric status. Arch Gen Psychiatry 48:77-83
33. Mayes S, Crites D, Bixlcr E, Humphrey B, Mattison R (1994), Methylphenidate and ADHD: influence of age, IQ and neurodevclopmental status. Dev Med ChiUNeurol 36:1099-1107
34. McMaster University Evidence-Based Practice Center. Tht Treatment of Attention-Deficit Hyperactivity Disorder: An Evidence Report (contract 290-97-0017). Washington DC: US Agency for Health Care Policy and Research, unpublished
35. MTA Cooperative Group (in press), Fourteen-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Arch Gen Psychiatry
36. NIH Consensus Statement (in press), Diagnosis and treatment of attention deficit hyperactivity disorder. NIH Consens Statement 1998 Nov 16-18; 16(2)
37. Patrick KS, Mueller RA, Gualtieri CT, Breese GR (1987), Pharmacokinetics and actions of methylphenidate. In: Psychopharmacolgy: The Third Generation of Progress, 3rd ed, Meltzer HY, ed. New York: Raven, pp 1387-1395
38. Pelham WE, Greenslade KE, Vodde-Hamilton MA et al. (1990), Relative efficacy of long-acting stimulants on ADHD children: a comparison of standard methylphenidate, Ritalin-SR, Dexedrine spansule, and pemoline. Pediatrics 86:226-237
39. Pelham WE, Milich R (1991), Individual differences in response to Ritalin in classwork and social behavior. In: Ritalin: Theory and Patient Management, Greenhill LL, Osman B, eds. New York: Mary Ann Liebert, pp 203-222 Physicians'Desk Reference (1998), Montvale, NJ: Medical Economics Data
40. Pliszka SR (1992), Comorbidity of attention-deficit hyperactivity disorder and overanxious disorder. J Am Acad Child Adolesc Pyckiatry 31:197-20)
41. Porrino LJ, Rapoporr (1983), A naturalistic assessment of the motor activity of hyperactive boys, II: stimulant drug effects. Arch Gen Psychiatry 40:688-697
42. Post RM (1980), Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance. Life Sei 26: 1275-1282
43. Rapoport JL, Buchsbaum MS, Weingartner H, Zahn P, Ludlow C, Mikkelsen EJ (1980), Dextroamphetamine: cognitive and behavioral effects in normal and hyperactive boys and normal men. Arch Gen Psychiatry 37:933-943
44. Rapport MD, DuPaul GJ, Kelly KL (1989), Attention deficit hyperactivity disorder and methylphenidate: the relationship between gross body weight and drug response in children. Psychofharmacol Bull 25:285-290
45. Richters J, Arnold L, Abikoff H et al. (1995), The National Institute of Mental Health Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit Hyperactivity Disorder (MTA), I: background and rationale. J Am Acad Child Adolesc Psychiatry 34:987-1000
46. Safer D, Zito J, Fine E (1996), Increased methylphenidate usage for attention deficit hyperactivity disorder in the 1990s. Pediatrics 98:1084-1088
47. Safer DJ, Allen RP (1989), Absence of tolerance to the behavioral effects of methylphenidate and inattentive children. Pediatrics 115:1003-1008
48. Satterfield JH, Canrwell DP, Schell A, BlaschkeT (1979), Growth of hyperactive children with methylphenidate. Arch Gen Psychiatry 36:212-217
49. Schachar R, Tannock R (1993), Childhood hyperactivity and psychostimulants: a review of extended treatment studies. J Child Adolesc Psychopharmacol 3:81-97
50. Schachar RJ, Ickowicz A, Tannock R (in press), Pharmacotherapy of ADHD. In: Handbook of Disruptive Behavior Disorders, Quay H, Hogan A, eds. New York: Plenum, pp 555-565
51. Schachar RJ, Tannock R, Cunningham C, Corkum PV (1997), Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J Am Acad Child Adolesc Psychiatry 36:754-763
52. Sherman M (1991), Prescribing practice of methylphenidate: the Suffolk County Study. In: Ritalin: Theory and Patient Management, Greenhill LL, Osman B, eds. New York: Mary Ann Licbert, pp 401-420
53. Solanto M (1998), Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94:127-152
54. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S (1996a), Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35:409-432
55. Spencer TJ, Biederman J, Harding M, O'Donnell D, Faraone SV, Wilens TE (1996b), Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 35:1460-1467
56. Swanson J (1993), Effect of stimulant medication on hyperactive children: a review of reviews. Except Child 60: 154-162
57. Swanson J, Kinsbourne M, Roberts W, Zucker K (1978), Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics 61:21-29
58. Swanson J, Lerner M, Williams L (1995), More frequent diagnosis of attention deficit-hyperactivity disorder. N EnglJ Med 333:944
59. Swanson J, Wigal S, Greenhill L et al. (1998), Analog classroom assessment of Adderall in children with ADHD. J Am Acad Child Adolesc Psychiatry 37:1-8
60. Tannock R, Ickowicz A, Schachar R (1995a), Differential effects of MPH on working memory in ADHD children with and without comorbid anxiety. JAm Acad Child Adolesc Psychiatry 34:886-896
61. Tannock R, Schachar R, Logan GD (1995b), Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children. J Abnorm Child Psychol 23:23 5-267
62. Thurber S, Walker C (1983), Medication and hyperactivity: a meta-analysis. JGen Psychiatry 108:79-86
63. US Drug Enforcement Administration, Office of Diversion Control (1996), Conference Report: Stimulant Use in the Treatment of ADHD. Washington, DC
64. Vitiello B, Burke L (in press), Generic methylphenidate versus brand Ritalin: which should be used? In: Ritalin: Theory and Practice, 2nd ed, Greenhill L, Osman B, eds. Larchmont, NY: Mary Ann Liebert
65. Volkow N, Wang G, Fowler J et al. (1998), Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155:1325-1331
66. Whalen C, Henker B, Buhrmester D, Hinshaw S, Huber A, Laski K (1989), Does stimulant medication improve the peer status of hyperactive children? J Consult Clin Psychol 57:545-549
67. Wilens TE, Biederman J (1992), The stimulants. Psychiatr Clin North Am 15:191-222
68. Winsberg B, Matinsky S, Kupietz S, Richardson E (1987), Is there dosedependent tolerance associated with chronic methylphenidate dierapy in hyperactive children: oral dose and plasma concentrations. Psychopharmacol Bull 23:107-110
69. Wroblewski B, Leary J, Phelan A, Whyte J, Manning K (1992), Methylphenidate and seizure frequency in brain injured patients with seizure disorders. J Clin Psychiatry 53:86-89